Clinical Performance Partners Launches New Web Site
Clinical Performance Partners, Inc. (CPP) announces the launch of their website (www.clinicalperformancepartners.com).
Contact: Beth Harper FOR IMMEDIATE RELEASE
Phone: 817-946-4892
Email: bharper@clinicalperformancepartners.com
CLINICAL PERFORMANCE PARTNERS LAUNCHES NEW WEBSITE
KELLER, TX June 19, 2008 – Clinical Performance Partners, Inc. (CPP) announces the launch of their website (www.clinicalperformancepartners.com).
“In addition to establishing a web presence for the company, the goal of the website is to serve as a valuable resource to the industry for all things related to patient recruitment / retention and site relationship management” says Beth Harper, President of Clinical Performance Partners, Inc.
The website features a listing of patient recruitment service providers with links to their websites. In addition, viewers can search for articles related to patient recruitment and site relationship management, as well as download sample tools and templates developed by CPP, Inc.
“As a long-time champion and advocate for educating the industry on the process and practice of patient recruitment, I am delighted to share my interest, experience and resources as we all strive to overcome the chronic challenges associated with patient recruitment” says Harper.
“Predicting, managing, supporting and enhancing site performance in clinical trials is not only our mission by my personal passion” notes Harper who celebrates some 25 years of “in the trenches” healthcare and clinical research experience this year.
About Clinical Performance Partners - CPP is a consulting firm dedicated to designing and implementing innovative and practical solutions for improving site performance and accelerating clinical trials results for the Life Sciences Industry. www.clinicalperformancepartners.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
